Chuck Dushman Promoted to Area Managing Partner at Chief Outsiders, Helping Companies Tackle their Growth Challenges and Opportunities
September 17, 2024 15:42 ET
|
Chief Outsiders
CHICAGO, IL, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Chief Outsiders, the nation’s largest provider of Fractional Executive Services to grow mid-market companies, is pleased to announce the promotion of...
8 Rivers Secures Investment from JX Nippon for First Commercial Deployment of the Calcite Direct Air Capture Technology
September 17, 2024 09:00 ET
|
8 Rivers
DURHAM, N.C., Sept. 17, 2024 (GLOBE NEWSWIRE) -- 8 Rivers Capital, LLC, a world-leading decarbonization technology and project developer, announced an investment from JX Nippon Oil Exploration...
IMU Biosciences expands leadership team with appointment of industry experts Dr. John Baker as Chief Executive Officer and Dr. Jason Brown as Chief Business Officer
September 17, 2024 02:00 ET
|
IMU Biosciences
IMU Biosciences expands leadership team with appointment of industry experts Dr. John Baker as Chief Executive Officer and Dr. Jason Brown as Chief Business Officer London, UK, 17 September 2024 –...
Immutep’s Efti in Combination with MSD’s KEYTRUDA® Leads to Positive Efficacy with Favourable Safety in First Line Head and Neck Cancer
September 16, 2024 08:00 ET
|
Immutep Limited
Results delivered in prestigious Proffered Paper oral presentation at ESMO Congress 2024In patients with any PD-L1 expression (CPS ≥1), efti in combination with KEYTRUDA outperformance is largest in...
Evaxion reports convincing one-year data from phase 2 trial on AI-designed personalized cancer vaccine EVX-01
September 16, 2024 07:00 ET
|
Evaxion Biotech
11 out of 16 patients had objective clinical responses, equaling a 69% Overall Response Rate15 out of the 16 patients had a reduction of their tumors (target lesions)79% of EVX-01’s vaccine targets...
Instil Bio and ImmuneOnco Announce Global Registrational Strategy for PD-L1xVEGF Bispecific Antibody, SYN-2510/IMM2510, in Non-Small Cell Lung Cancer and Triple-Negative Breast Cancer
September 16, 2024 06:00 ET
|
Instil Bio
Global registrational strategy in first-line non-squamous and squamous non-small cell lung cancer (NSCLC)Global registrational strategy in first-line triple-negative breast cancer (TNBC)Initiation of...
AAVantgarde announces first patient dosed in First-In-Human Phase 1/2 LUCE-1 study, evaluating AAVB-081 (Dual-AAV) in retinitis pigmentosa related to Usher Syndrome type 1B
September 16, 2024 02:00 ET
|
AAVantgarde Bio
AAVantgarde announces first patient dosed in First-In-Human Phase 1/2 LUCE-1 study
Medigene Presents Progress on KRAS Library and UniTope & TraCR Technology at ESMO 2024
September 14, 2024 07:30 ET
|
Medigene AG
Planegg/Martinsried, September 14, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an oncology platform company focused on the research and development of T cell receptor...
Recognizing Leadership and Commitment, Chief Outsiders Promotes Dina Baker to Area Managing Partner
September 12, 2024 09:46 ET
|
Chief Outsiders
BOSTON, MA, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Chief Outsiders, the nation’s largest provider of Fractional Executive Services to grow mid-market companies, recently promoted Dina Baker from the...
The European Art of Taste 的獨家清新飲品：以蔬果製成的佳品
September 12, 2024 09:38 ET
|
The European Art of Taste
費拉拉，意大利, Sept. 12, 2024 (GLOBE NEWSWIRE) -- 夏天過後如何保持涼爽？ 完美的解決方案來自由 The European Art of Taste 項目組精選的最優質水果：美味奇異果和多汁香橙！ 今天，The European Art of Taste 推出了特別的「清爽飲品系列」——每款飲品都易於製作，而且充滿夏日的清新氣息。 ...